Biomarker testing in oncology – Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL

In personalized medicine, predictive biomarker testing is the basis for an appropriate choice of therapy for patients with cancer. An important tool for laboratories to ensure accurate results is participation in external quality assurance (EQA) programs. Several providers offer predictive EQA progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufraing, K., Fenizia, F., Torlakovic, E., Wolstenholme, N., Deans, Z. C., Rouleau, E., Vyberg, M., Parry, S., Schuuring, E., Dequeker, Elisabeth M. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550230/
https://www.ncbi.nlm.nih.gov/pubmed/33047156
http://dx.doi.org/10.1007/s00428-020-02928-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550230/
https://www.ncbi.nlm.nih.gov/pubmed/33047156
http://dx.doi.org/10.1007/s00428-020-02928-z

Ejemplares similares